Cadrenal TherapeuticsCVKD
13F holders, Q4 2024 (December 31)1holders −8
1new positions
0sold out
$14.48avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Cadrenal Therapeutics Inc. (CVKD) in their 13F filings, down 8 from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Farther Finance Advisors, LLC ($362).
- Company
- Cadrenal Therapeutics Inc.
- CUSIP
- 127636108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $362 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q4 2024: 25 shares bought, net +25 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Farther Finance Advisors, LLC | 0.00% | New | 25 | $362 |
"% of holder's portfolio" is CVKD's weight in each manager's 13F, not the share of Cadrenal Therapeutics Inc. the manager owns.